Last reviewed 2026-04-20 · How we verify

Fluocinolone Acetonide (FLUOCINOLONE)

At a glance

Approved indications

• Corticosteroid-responsive dermatoses

Common side effects

• Skin atrophy
• Miliaria
• Hypopigmentation
• Acneiform eruptions
• Striae
• Hypertrichosis
• Folliculitis
• Secondary infection
• Dryness
• Maceration of the skin
• Irritation
• Allergic contact dermatitis

Key clinical trials

• The Therapeutic Effect of Curcumin in Nanogels Compared to 0.1% FAO in the Management of Oral Lichen Planus (NA)
• Frequency and Intensity of Inflammatory Relapses in Patients With Non-infectious Posterior Uveitis Treated With a Fluocinolone Acetonide Implant
• Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant
• Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy (PHASE3)
• Comparison of Efficacy of Metformin Gel 30% vs Triple Combination Cream (Hydroquinone 4%, Flucinolone Acetonide 0.01%, Tretinoin 0.025%) in Treatment of Melasma in Tertiary Care Hospital Karachi (NA)
• A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (PHASE3)
• Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis (NA)
• Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery. (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Fluocinolone Acetonide CI brief — competitive landscape report
• Fluocinolone Acetonide updates RSS · CI watch RSS
• Eurofarma portfolio CI